Navigation Links
Novasep and Mega Sign a Strategic Technology Partnership to Develop Whey Treatment Solutions for the Dairy Industry
Date:11/10/2010

Novasep and Mega Sign a Strategic Technology... -- POMPEY, France and STRAZ POD RASKEM, Czech Republic, November 10, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Food & Beverages, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Joint Ventures Click to view news release full screen  

Novasep and Mega Sign a Strategic Technology Partnership to Develop Whey Treatment Solutions for the Dairy Industry

   

Electrodialysis and Manufacturing Process Companies Come Together to Design the Most Cost-Effective Whey Demineralization Solutions Offering Guaranteed Performance

POMPEY, France and STRAZ POD RASKEM, Czech Republic, November 10, 2010 /PRNewswire/ -- Novasep, a leading supplier of manufacturing solutions to the life sciences industry, and Mega, a technology leader in electrodialysis, today announce a strategic technology partnership in the field of whey treatment. The companies will combine Mega's advanced electrodialysis technology with the whey demineralization solutions from Novasep Process, the biomolecule division of Novasep that provides purification process lines for the fields of bio-industries, food ingredients, and biopharmaceuticals. This will enable both partners to propose a range of cost-effective processes for all qualities of demineralized whey, with guaranteed performance.

The alliance brings a significant addition to the technology portfolio of Novasep Process, being able to now offer an even wider range of manufacturing process solutions to customers in the dairy industry. The cooperation will also provide Novasep Process with better access to Central and Eastern European as well as Indian markets, in which Mega has a strong commercial presence. Conversely, it will also increase the visibility of Mega's electrodialysis technology in the other geographic zones through the active promotion by Novasep and through its integration within global processes guaranteed by Novasep.

Today, alternate whey demineralization solutions using electrodialysis are energy-consuming and require frequent replacement of membranes. On the contrary, Mega's proprietary technology reduces electricity consumption and provides a membrane lifetime guarantee for up to 4 years, strongly minimizing maintenance costs. Mega and Novasep Process have designed a range of processes optimized for any crude and demineralized whey qualities, associating Mega's technology with Novasep Process technologies including ion exchange and nanofiltration (NF). Through this alliance, Novasep Process' offering includes process design and development, turn-key system engineering, supply and commissioning, customer service and consumables.

"I am delighted with Novasep Process' cooperation with Mega, a company that is a technology leader in electro-membrane processes," said Antoine Baule, president of Novasep Process. "This alliance further enriches Novasep Process' portfolio of technologies and will enable us to better serve our clients in the dairy industry for their whey processing requirements."

This alliance in the process field enhances the capabilities of both partners to better serve their respective customers in the field. Lubos Novak, president and CEO of Mega, added, "Novasep is a global leader in process solutions for food ingredient manufacturing. This partnership will enable both companies to design strongly enhanced solutions, through collaborative product and process development."

About MEGA

MEGA is a specialist in electrodialysis (ED), fully integrated in the design and production of ED membranes as well as ED skids and systems. Its unique technology currently has the highest performance of any on the market, and is applied in a variety of processes, including water treatment, purification of organic solutions and whey demineralization.

About Novasep

Novasep develops, markets and operates innovative technologies providing life science industries with safe and cost-effective production of active molecules. The global manufacturing solutions offered by Novasep include process development services; purification equipment and systems; contract manufacturing services; and complex active molecules. The applications of Novasep's offering cover the pharmaceutical, biopharmaceutical, food, functional ingredients and bio-industries markets.

Website: http://www.mega.cz


'/>"/>
SOURCE Novasep
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films
2. ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute
3. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
4. Pilgrim Software and Portford Solutions Sign Strategic Reseller Agreement
5. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
6. Savient Pharmaceuticals Provides Update on Strategic Alternatives Process
7. Frost & Sullivan: Strategic Partnerships Crucial to Medical Device Success
8. International SOS Establishes a Strategic Alliance With RMSI
9. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
10. Pfizer To Review Strategic Alternatives For Capsugel
11. Objet Geometries and Javelin Technologies Form Strategic Distribution Partnership for 3D Printers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
(Date:2/11/2016)... -- Stem cells are primitive cells found in all ... capacity to differentiate into mature cell types Stem cells ... mouse embryonic stem cells were derived from embryos in ... first culturing of embryonic stem cells from non-human primates ... 2006 As a result of these discoveries, stem cells ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... , ... The producers of Enterprises TV are pleased to present ... world of instantaneous consumption proves very convenient for businesses. With new technologies constantly becoming ... which pollutes our air, water, and soil. It can also threaten the lives of ...
(Date:2/13/2016)... , ... February 13, 2016 , ... In the early ... They’ll groom themselves to perfection, go out of their way to be romantic, and ... just take a look at any online dating profile. , A recent study ...
(Date:2/12/2016)... ... 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett is ... these scholarships is to encourage applicants to pursue a degree in their field of ... parishes. , “We have available jobs in St. Landry and Evangeline Parishes that ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed ... p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed ... pharmaceutical products, garnering increased attention from all stakeholders in the development of new ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... that nominations have closed for the ISE Southeast Awards 2016. Finalists and winners ... at the ISE® Southeast Executive Forum and Awards Gala on March 15, 2016 ...
Breaking Medicine News(10 mins):